Sunshield Chemicals Q1 Results: EBITDA Jumps 63%, Net Profit Surges 98% YoY
Sunshield Chemicals reported strong Q1FY26 results with EBITDA jumping 63% to 205M rupees and EBITDA margin expanding to 16.05% from 11.08% YoY. Net profit after tax surged 98% to ₹13.49 crore, while revenue from operations grew 12% to ₹127.47 crore, supported by a sharp 91% decline in finance costs and effective cost management.

*this image is generated using AI for illustrative purposes only.
Sunshield Chemicals Limited reported a significant surge in profitability for the quarter ended June 30, 2026, with net profit after tax (PAT) rising 98% year-on-year to ₹13.49 crore from ₹6.82 crore in the corresponding period of FY25. Revenue from operations grew by 12% to ₹127.47 crore, up from ₹113.88 crore in Q1FY25, reflecting robust demand in its speciality chemicals segment. The strong bottom-line performance was supported by effective cost management and higher operational efficiency, with EBITDA climbing to 205M rupees from 126M rupees in the year-ago period, and EBITDA margin expanding sharply to 16.05% from 11.08%. Earnings per share (EPS) also improved to ₹15.34 from ₹9.17 in the previous year.
The Board of Directors approved the unaudited financial results during a meeting held on August 11, 2026, in Mumbai. The results were reviewed by the Audit Committee and subsequently ratified by the Board. CNK & Associates LLP, the independent auditors, issued an unmodified limited review report on the financial statements, confirming that nothing came to their attention to suggest the results contained material misstatements. The financial statements were prepared in accordance with Ind AS 34 and Section 133 of the Companies Act, 2013.
Financial Performance Highlights
The company's total income for the quarter stood at ₹128.41 crore, comprising ₹127.47 crore from operations and ₹0.94 crore from other income. Total expenses were recorded at ₹110.36 crore, resulting in a profit before tax of ₹18.05 crore. Tax expenses amounted to ₹4.56 crore, including current tax of ₹4.45 crore and deferred tax of ₹0.11 crore. The key financial metrics for the quarter are summarised below:
| Metric: | Q1FY26 | Q1FY25 | YoY Change |
|---|---|---|---|
| Revenue from Operations: | ₹12,747 lakhs | ₹11,388 lakhs | +12% |
| Other Income: | ₹94 lakhs | ₹146 lakhs | -36% |
| Total Income: | ₹12,841 lakhs | ₹11,534 lakhs | +11% |
| Total Expenses: | ₹11,036 lakhs | ₹10,618 lakhs | +4% |
| EBITDA: | 205M rupees | 126M rupees | +63% |
| EBITDA Margin: | 16.05% | 11.08% | +497 bps |
| Profit Before Tax: | ₹1,805 lakhs | ₹916 lakhs | +97% |
| Net Profit After Tax: | ₹1,349 lakhs | ₹682 lakhs | +98% |
| EPS (Basic & Diluted): | ₹15.34 | ₹9.17 | +67% |
Operational Efficiency
Cost of materials consumed increased to ₹79.55 crore from ₹86.99 crore in the prior year quarter, while employee benefits expense rose modestly to ₹6.36 crore from ₹5.64 crore. Finance costs remained low at ₹0.20 crore compared to ₹2.27 crore in Q1FY25, contributing significantly to the improved pre-tax margin. Depreciation charges were recorded at ₹3.15 crore, up from ₹2.65 crore in the same period last year.
What the Numbers Show
The divergence between revenue growth (12%) and expense growth (4%) highlights improved operating leverage for Sunshield Chemicals in Q1FY26. The EBITDA margin expansion of nearly 500 basis points to 16.05% underscores the company's ability to translate top-line growth into stronger operating profitability. While material costs constituted the largest expense head at ₹79.55 crore, the company managed to contain overall cost inflation despite rising input prices. The sharp decline in finance costs, down nearly 91% from the previous year, further boosted the bottom line, demonstrating resilient margin expansion in the speciality chemicals sector.
Historical Stock Returns for Sunshield Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.36% | +3.43% | +2.80% | +45.74% | +44.31% | +243.85% |
Can Sunshield Chemicals sustain its 16.05% EBITDA margin in Q2FY26 given the potential volatility in raw material costs for speciality chemicals?
How will the significant reduction in finance costs impact the company's future capital allocation strategy, such as debt repayment versus expansion investments?
What specific operational efficiencies or pricing power enabled Sunshield to achieve 98% PAT growth while revenue only grew by 12%?


































